148 related articles for article (PubMed ID: 12213220)
21. Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition.
Fan Z; Lu Y; Wu X; DeBlasio A; Koff A; Mendelsohn J
J Cell Biol; 1995 Oct; 131(1):235-42. PubMed ID: 7559780
[TBL] [Abstract][Full Text] [Related]
22. Increase in secretion of glial cell line-derived neurotrophic factor from glial cell lines by inhibitors of vacuolar ATPase.
Nishiguchi M; Tokugawa K; Yamamoto K; Akama T; Nozawa Y; Chaki S; Ueki T; Kameo K; Okuyama S
Neurochem Int; 2003 May; 42(6):493-8. PubMed ID: 12547648
[TBL] [Abstract][Full Text] [Related]
23. Novel marine and microbial natural product inhibitors of vacuolar ATPase.
Beutler JA; McKee TC
Curr Med Chem; 2003 May; 10(9):787-96. PubMed ID: 12678782
[TBL] [Abstract][Full Text] [Related]
24. Specific inhibitors of vacuolar type H(+)-ATPases induce apoptotic cell death.
Nishihara T; Akifusa S; Koseki T; Kato S; Muro M; Hanada N
Biochem Biophys Res Commun; 1995 Jul; 212(1):255-62. PubMed ID: 7612014
[TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor receptor-dependent cytotoxic effect by an EGF-ribonuclease conjugate on human cancer cell lines--a trial for less immunogenic chimeric toxin.
Jinno H; Ueda M; Ozawa S; Kikuchi K; Ikeda T; Enomoto K; Kitajima M
Cancer Chemother Pharmacol; 1996; 38(4):303-8. PubMed ID: 8674151
[TBL] [Abstract][Full Text] [Related]
26. The vacuolar-type ATPase inhibitor archazolid increases tumor cell adhesion to endothelial cells by accumulating extracellular collagen.
Luong B; Schwenk R; Bräutigam J; Müller R; Menche D; Bischoff I; Fürst R
PLoS One; 2018; 13(9):e0203053. PubMed ID: 30204757
[TBL] [Abstract][Full Text] [Related]
27. Theanaphthoquinone inhibits fatty acid synthase expression in EGF-stimulated human breast cancer cells via the regulation of EGFR/ErbB-2 signaling.
Weng MS; Ho CT; Ho YS; Lin JK
Toxicol Appl Pharmacol; 2007 Jan; 218(2):107-18. PubMed ID: 17182072
[TBL] [Abstract][Full Text] [Related]
28. Combined effects of EGFR tyrosine kinase inhibitors and vATPase inhibitors in NSCLC cells.
Jin HO; Hong SE; Kim CS; Park JA; Kim JH; Kim JY; Kim B; Chang YH; Hong SI; Hong YJ; Park IC; Lee JK
Toxicol Appl Pharmacol; 2015 Aug; 287(1):17-25. PubMed ID: 25981168
[TBL] [Abstract][Full Text] [Related]
29. Thymineless death in colon carcinoma cells is mediated via fas signaling.
Houghton JA; Harwood FG; Tillman DM
Proc Natl Acad Sci U S A; 1997 Jul; 94(15):8144-9. PubMed ID: 9223329
[TBL] [Abstract][Full Text] [Related]
30. Clavilactones, a novel class of tyrosine kinase inhibitors of fungal origin.
Cassinelli G; Lanzi C; Pensa T; Gambetta RA; Nasini G; Cuccuru G; Cassinis M; Pratesi G; Polizzi D; Tortoreto M; Zunino F
Biochem Pharmacol; 2000 Jun; 59(12):1539-47. PubMed ID: 10799650
[TBL] [Abstract][Full Text] [Related]
31. Fungal metabolite FR901228 inhibits c-Myc and Fas ligand expression.
Wang R; Brunner T; Zhang L; Shi Y
Oncogene; 1998 Sep; 17(12):1503-8. PubMed ID: 9794227
[TBL] [Abstract][Full Text] [Related]
32. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
33. Differential dose-dependent effects of epidermal growth factor on gene expression in A431 cells: evidence for a signal transduction pathway that can bypass Raf-1 activation.
Silvy M; Martin PM; Chajry N; Berthois Y
Endocrinology; 1998 May; 139(5):2382-91. PubMed ID: 9564849
[TBL] [Abstract][Full Text] [Related]
34. Peptabody-EGF: a novel apoptosis inducer targeting ErbB1 receptor overexpressing cancer cells.
Fattah OM; Cloutier SM; Kündig C; Felber LM; Gygi CM; Jichlinski P; Leisinger HJ; Gauthier ER; Mach JP; Deperthes D
Int J Cancer; 2006 Nov; 119(10):2455-63. PubMed ID: 16858684
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
[TBL] [Abstract][Full Text] [Related]
36. Effect of a novel vacuolar-H+-ATPase inhibitor on cell and tumor response to camptothecins.
Petrangolini G; Supino R; Pratesi G; Dal Bo L; Tortoreto M; Croce AC; Misiano P; Belfiore P; Farina C; Zunino F
J Pharmacol Exp Ther; 2006 Sep; 318(3):939-46. PubMed ID: 16714402
[TBL] [Abstract][Full Text] [Related]
37. Bcl-2 inhibits calcineurin-mediated Fas ligand expression in antitumor drug-treated baby hamster kidney cells.
Simizu S; Shibasaki F; Osada H
Jpn J Cancer Res; 2000 Jul; 91(7):706-14. PubMed ID: 10920278
[TBL] [Abstract][Full Text] [Related]
38. Specific inhibitors of vacuolar H(+)-ATPase trigger apoptotic cell death of osteoclasts.
Okahashi N; Nakamura I; Jimi E; Koide M; Suda T; Nishihara T
J Bone Miner Res; 1997 Jul; 12(7):1116-23. PubMed ID: 9200012
[TBL] [Abstract][Full Text] [Related]
39. Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity.
Gulli LF; Palmer KC; Chen YQ; Reddy KB
Cell Growth Differ; 1996 Feb; 7(2):173-8. PubMed ID: 8822200
[TBL] [Abstract][Full Text] [Related]
40. Cryptosporidium parvum induces apoptosis in biliary epithelia by a Fas/Fas ligand-dependent mechanism.
Chen XM; Gores GJ; Paya CV; LaRusso NF
Am J Physiol; 1999 Sep; 277(3):G599-608. PubMed ID: 10484385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
